EP Patent

EP3045461A1 — Processes for preparing dolutegravir and analogues thereof

Assigned to Lek Pharmaceuticals dd · Expires 2016-07-20 · 10y expired

What this patent protects

The present invention relates to processes for preparing substances with antiviral activity, in particular the integrase inhibitor dolutegravir and analogues thereof, as well as intermediates useful in the processes.

USPTO Abstract

The present invention relates to processes for preparing substances with antiviral activity, in particular the integrase inhibitor dolutegravir and analogues thereof, as well as intermediates useful in the processes.

Drugs covered by this patent

Patent Metadata

Patent number
EP3045461A1
Jurisdiction
EP
Classification
—
Expires
2016-07-20
Drug substance claim
No
Drug product claim
No
Assignee
Lek Pharmaceuticals dd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.